Drug intelligence / Profile preview

2-iminobiotin

Development stage
Phase 2
Lead developer
Neurophyxia
Modality
Small Molecules
Administration
Intravenous
01

Overview

2-Iminobiotin is a synthetic small molecule and analog of biotin (vitamin B7), classified as a biotin derivative. It acts as a selective inhibitor of neuronal nitric oxide synthase (nNOS) and inducible nitric oxide synthase (iNOS), enzymes involved in the production of nitric oxide. By inhibiting these enzymes, 2-Iminobiotin exhibits neuroprotective properties and has been investigated for its potential to reduce brain injury following hypoxic or ischemic events such as perinatal asphyxia. The compound has orphan drug designation in both the US and Europe for neonatal hypoxic and ischemic brain injury[5][7][9].

Other names
GuanidinobiotinHexahydro-2-imino-1h-thieno(3,4-d)imidazole-4-pentanoic acid5-(3aR,6S,6aS)-2-amino-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-6-pentanoic acid
02

Targets

NOS1 (nNOS)NOS2 (Nitric Oxide Synthase 2)

Beyond the preview

Go deeper on 2-iminobiotin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-iminobiotin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call